Real-world evidence as an approach to assessing the impact, efficacy and safety of pharmaceuticals is rapidly growing in importance. In Canada, there has been an increasing demand for RWE to play a role in market access strategies and clinical and regulatory decision making.
To better understanding the current environment, IQVIA Canada’s Real World Solutions team asked RWE leaders at innovative Canadian pharmaceutical companies about how prepared they are to capture the strategic value of RWE.
The main findings from the survey highlight significant gaps between current best practices and the future demands of regulatory bodies and other stakeholders.
Source: https://www.iqvia.com/locations/canada/library/publications/iqvia-real-world-evidence-benchmarking-survey
Download the Report: https://www.iqvia.com/-/media/iqvia/pdfs/canada/publications/iqvia-real-world-evidence-benchmarking-survey.pdf